BVS

BIOVENTUS INC

BVS·09075A108·US·Common Stock·Healthcare - Medical Devices-13D/G

BVS (BIOVENTUS INC) is held by 93 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($32.4M), ROYCE & ASSOCIATES LP ($17.3M), VANGUARD CAPITAL MANAGEMENT LLC ($16.5M). Net institutional sentiment: Bullish.

93
Holders
(8 Elite)
$210.4M
Total Value
69% (95)
Consensus
66 buying - 29 selling
13F: Insider & Congress: Updated regularly
BVS

Smart Money Verdict

View all
Loading verdict
Held by 93 funds
8 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Mar 13, 2026 · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.5.0%Jul 27, 2026
InsiderMMMcMurry-Heath MichelleSell $105KMar 11, 2026
ActivistNANantahala Capital Management, LLC9.0%Feb 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.4M(+9.7%)$32.4M0.0%+39.09%
32
Increased
1.8M(+18.9%)$17.3M0.1%+45.60%
40
Increased
1.8M(+2.2%)$16.5M0.0%+59.57%
29
Increased
1.4M(+16.9%)$12.9M0.0%+68.10%
32
Increased
1.4M(+118.4%)$12.8M0.0%+46.21%
45
Increased
1.1M(+29.2%)$10.7M0.0%+59.84%
35
Increased
1.1M(+11.8%)$10.4M0.0%+64.87%
31
Increased
1M(+7.2%)$9.8M0.0%+58.99%
30
Increased
748,358(+385.5%)$7.1M0.0%+50.28%
44
Increased
736,000(+50.4%)$6.9M0.0%+85.25%
38
Increased
652,367(+37.8%)$6.2M0.0%+65.21%
36
Increased
452,850(+14.3%)$4.3M0.0%+43.28%
31
Increased
443,824(+22.3%)$4.2M0.0%+31.33%
32
Increased
394,520(+103.6%)$3.7M0.0%+53.58%
43
Increased
391,859(+4.8%)$3.7M0.0%+43.05%
28
Increased
327,838(+2.1%)$3.1M0.0%+59.57%
27
Decreased
326,124(-4.1%)$3.1M0.0%+39.83%
0
Increased
317,208(+3.8%)$3M0.0%+91.11%
27
Increased
269,267(+21.9%)$2.5M0.0%+76.37%
31
Decreased
250,278(-10.3%)$2.4M0.0%+64.53%
0

Showing 1-20 of 102

1 / 6
BVSBVSBIOVENTUS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used